226 related articles for article (PubMed ID: 35603655)
21. The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn's disease.
Ono Y; Kanmura S; Morinaga Y; Oda K; Kawabata K; Arima S; Sasaki F; Nasu Y; Tanoue S; Hashimoto S; Taguchi H; Uto H; Tsubouchi H; Ido A
BMC Gastroenterol; 2017 Mar; 17(1):40. PubMed ID: 28284201
[TBL] [Abstract][Full Text] [Related]
22. Terpenes: Modulating anti-inflammatory signaling in inflammatory bowel disease.
Rivera Rodríguez R; Johnson JJ
Pharmacol Ther; 2023 Aug; 248():108456. PubMed ID: 37247693
[TBL] [Abstract][Full Text] [Related]
23. The genetics of Crohn's disease and ulcerative colitis--status quo and beyond.
Ellinghaus D; Bethune J; Petersen BS; Franke A
Scand J Gastroenterol; 2015 Jan; 50(1):13-23. PubMed ID: 25523552
[TBL] [Abstract][Full Text] [Related]
24. Chemokine and cytokine levels in inflammatory bowel disease patients.
Singh UP; Singh NP; Murphy EA; Price RL; Fayad R; Nagarkatti M; Nagarkatti PS
Cytokine; 2016 Jan; 77():44-9. PubMed ID: 26520877
[TBL] [Abstract][Full Text] [Related]
25. Treat-to-Target in Inflammatory Bowel Diseases, What Is the Target and How Do We Treat?
Agrawal M; Colombel JF
Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):421-436. PubMed ID: 31078245
[TBL] [Abstract][Full Text] [Related]
26. Serum transglutaminase in inflammatory bowel diseases.
D'Argenio G; Cicacci C; Sorrentini I; Iovino P; Gatto A; Cosenza V; Mazzacca G
J Clin Gastroenterol; 1990 Aug; 12(4):400-4. PubMed ID: 1975816
[TBL] [Abstract][Full Text] [Related]
27. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic and Genotypic Characterisation of Inflammatory Bowel Disease Presenting Before the Age of 2 years.
Kammermeier J; Dziubak R; Pescarin M; Drury S; Godwin H; Reeve K; Chadokufa S; Huggett B; Sider S; James C; Acton N; Cernat E; Gasparetto M; Noble-Jamieson G; Kiparissi F; Elawad M; Beales PL; Sebire NJ; Gilmour K; Uhlig HH; Bacchelli C; Shah N
J Crohns Colitis; 2017 Jan; 11(1):60-69. PubMed ID: 27302973
[TBL] [Abstract][Full Text] [Related]
29. Emerging roles of host and microbial bioactive lipids in inflammatory bowel diseases.
Kayama H; Takeda K
Eur J Immunol; 2023 Aug; 53(8):e2249866. PubMed ID: 37191284
[TBL] [Abstract][Full Text] [Related]
30. Dynamic role of macrophage CX3CR1 expression in inflammatory bowel disease.
Li J; Zhou H; Fu X; Zhang M; Sun F; Fan H
Immunol Lett; 2021 Apr; 232():39-44. PubMed ID: 33582183
[TBL] [Abstract][Full Text] [Related]
31. Food as Treatment of Inflammatory Bowel Diseases.
Maldonado-Contreras A
Infect Immun; 2022 May; 90(5):e0058321. PubMed ID: 35323020
[TBL] [Abstract][Full Text] [Related]
32. Inflammatory bowel disease.
Knigge KL
Clin Cornerstone; 2002; 4(4):49-60. PubMed ID: 12739326
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
Fernandes P; MacSharry J; Darby T; Fanning A; Shanahan F; Houston A; Brint E
Clin Exp Immunol; 2016 Mar; 183(3):358-68. PubMed ID: 26462859
[TBL] [Abstract][Full Text] [Related]
34. Critical roles of G protein-coupled receptors in regulating intestinal homeostasis and inflammatory bowel disease.
Feng Z; Sun R; Cong Y; Liu Z
Mucosal Immunol; 2022 May; 15(5):819-828. PubMed ID: 35732818
[TBL] [Abstract][Full Text] [Related]
35. Macrophage-Specific NF-κB Activation Dynamics Can Segregate Inflammatory Bowel Disease Patients.
Papoutsopoulou S; Burkitt MD; Bergey F; England H; Hough R; Schmidt L; Spiller DG; White MHR; Paszek P; Jackson DA; Martins Dos Santos VAP; Sellge G; Pritchard DM; Campbell BJ; Müller W; Probert CS
Front Immunol; 2019; 10():2168. PubMed ID: 31572379
[TBL] [Abstract][Full Text] [Related]
36. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
[TBL] [Abstract][Full Text] [Related]
37. Pathology of inflammatory bowel disease.
Gramlich T; Petras RE
Semin Pediatr Surg; 2007 Aug; 16(3):154-63. PubMed ID: 17602970
[TBL] [Abstract][Full Text] [Related]
38. Serum levels of C1q/TNF-related protein-3 in inflammatory bowel disease patients and its inverse association with inflammatory cytokines and insulin resistance.
Mohamadinarab M; Ahmadi R; Gholamrezayi A; Rahvar F; Naghdalipour M; Setayesh L; Moradi N; Fadaei R; Chamani E; Tavakoli T; Esteghamati A
IUBMB Life; 2020 Aug; 72(8):1698-1704. PubMed ID: 32311832
[TBL] [Abstract][Full Text] [Related]
39. Role of contrast-enhanced ultrasonography in the management of chronic inflammatory bowel disease.
Garre Sánchez MC
Rev Esp Enferm Dig; 2021 Apr; 113(4):237-239. PubMed ID: 33494614
[TBL] [Abstract][Full Text] [Related]
40. Immunotherapy of inflammatory bowel diseases: current concepts and future perspectives.
Neurath MF
Arch Immunol Ther Exp (Warsz); 2000; 48(2):81-4. PubMed ID: 10807047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
